Associate Professor of Medicine
Dr. Baljevic’s research interests include immunotherapies such as CAR-T Cell treatment, bITE antibodies and other T cell therapies, genetic causes of proteasome inhibitor resistance and stem cell transplant.
years treating myeloma: 2
Number of Myeloma Patients Treated Annually: 150
Details & contact info
South 44th Street
Omaha, NE, United States, 68131
Send a message to Muhamed Baljevic, MD